(Total Views: 98)
Posted On: 02/15/2024 8:20:46 AM
Post# of 9

$SNYNF News Article - Press Release: Phase 2 data published in NEJM show potential of frexalimab as high-efficacy therapy in relapsing MS https://marketwirenews.com/news-releases/pres...04198.html


My Twitter: WhyteStocks